[HTML][HTML] Evolving therapeutic landscape in follicular lymphoma: a look at emerging and investigational therapies

W Hanel, N Epperla - Journal of Hematology & Oncology, 2021 - Springer
Follicular Lymphoma (FL) is the most common subtype of indolent B cell non-Hodgkin
lymphoma. The clinical course can be very heterogeneous with some patients being safely …

[HTML][HTML] Evolving therapeutic landscape in follicular lymphoma: a look at emerging and investigational therapies

W Hanel, N Epperla - Journal of Hematology & Oncology, 2021 - ncbi.nlm.nih.gov
Follicular Lymphoma (FL) is the most common subtype of indolent B cell non-Hodgkin
lymphoma. The clinical course can be very heterogeneous with some patients being safely …

Evolving therapeutic landscape in follicular lymphoma: a look at emerging and investigational therapies

W Hanel, N Epperla - Journal of Hematology & Oncology, 2021 - cir.nii.ac.jp
抄録< jats: title> Abstract</jats: title>< jats: p> Follicular Lymphoma (FL) is the most common
subtype of indolent B cell non-Hodgkin lymphoma. The clinical course can be very …

[HTML][HTML] Evolving therapeutic landscape in follicular lymphoma: a look at emerging and investigational therapies

W Hanel, N Epperla - Journal of Hematology & …, 2021 - jhoonline.biomedcentral.com
Follicular Lymphoma (FL) is the most common subtype of indolent B cell non-Hodgkin
lymphoma. The clinical course can be very heterogeneous with some patients being safely …

Evolving therapeutic landscape in follicular lymphoma: a look at emerging and investigational therapies

W Hanel, N Epperla - Journal of hematology & oncology, 2021 - pubmed.ncbi.nlm.nih.gov
Follicular Lymphoma (FL) is the most common subtype of indolent B cell non-Hodgkin
lymphoma. The clinical course can be very heterogeneous with some patients being safely …

[PDF][PDF] Evolving therapeutic landscape in follicular lymphoma: a look at emerging and investigational therapies

W Hanel, N Epperla - 2021 - academia.edu
Follicular Lymphoma (FL) is the most common subtype of indolent B cell non-Hodgkin
lymphoma. The clinical course can be very heterogeneous with some patients being safely …

Evolving therapeutic landscape in follicular lymphoma: a look at emerging and investigational therapies

W Hanel, N Epperla - Journal of Hematology & Oncology, 2021 - search.proquest.com
Follicular Lymphoma (FL) is the most common subtype of indolent B cell non-Hodgkin
lymphoma. The clinical course can be very heterogeneous with some patients being safely …

Evolving therapeutic landscape in follicular lymphoma: a look at emerging and investigational therapies.

W Hanel, N Epperla - Journal of Hematology & Oncology, 2021 - europepmc.org
Follicular Lymphoma (FL) is the most common subtype of indolent B cell non-Hodgkin
lymphoma. The clinical course can be very heterogeneous with some patients being safely …

Evolving therapeutic landscape in follicular lymphoma: a look at emerging and investigational therapies.

W Hanel, N Epperla - Journal of Hematology & Oncology, 2021 - search.ebscohost.com
Follicular Lymphoma (FL) is the most common subtype of indolent B cell non-Hodgkin
lymphoma. The clinical course can be very heterogeneous with some patients being safely …

Evolving therapeutic landscape in follicular lymphoma: a look at emerging and investigational therapies

W Hanel, N Epperla - Journal of Hematology and …, 2021 - ohiostate.elsevierpure.com
Follicular Lymphoma (FL) is the most common subtype of indolent B cell non-Hodgkin
lymphoma. The clinical course can be very heterogeneous with some patients being safely …